Matthew Slarve

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection”.

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab265

N/A

0DataRank · unranked

28 citations

Jun Yan, Brian Luna, Yuli Talyansky, Matthew Slarve, Robert A. Bonomo +2 more

Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis

Vaccine(2022)10.1016/j.vaccine.2022.05.057

N/A

0DataRank · unranked

14 citations

Nickolas J. Holznecht, Hernan Reza, Adrienne P. Gilkes, Ielyzaveta Slarve, Jon Olson +5 more

Development of a Bispecific Antibody Targeting Clinical Isolates of Acinetobacter baumannii

The Journal of Infectious Diseases(2023)10.1093/infdis/jiac499

N/A

0DataRank · unranked

20 citations

Jun Yan, Matthew Slarve, Rachel Li, Jason A. Junge, Brian Luna +4 more

Clinical assays rapidly predict bacterial susceptibility to monoclonal antibody therapy

JCI Insight(2024)10.1172/jci.insight.174799

N/A

0DataRank · unranked

4 citations

Neven Bowler, Elizabeth Burk, Jun Yan, Ulrike MacDonald, Thomas A. Russo +3 more